Question to the Home Office:

To ask the Secretary of State for the Home Department, what recent assessment she has made of the adequacy of the classification of ketamine as a Class B drug under the Misuse of Drugs Act 1971; and if she will make an assessment of the potential merits of reviewing that classification.

No recent assessment has been made. Ketamine was moved from Class C to Class B in 2014, in accordance with advice provided by the Advisory Council on the Misuse of Drugs (ACMD). The ACMD’s recommendation was based on evidence of ketamine’s potential for harm at that time. The Government continues to assess any emerging evidence of harm and keeps drugs controls under review. Any decisions about drug classification are made after seeking expert advice from the ACMD.